New HIV Vaccine Strategy Generates Broad Immunity

Scientists, led by Dr. Peter Kwong at the National Institute of Allergy and Infectious Diseases, published a study in Nature showing a novel vaccination approach effectively generates broadly neutralizing antibodies against HIV-1 in animal models. This method focuses on B cell priming, which means it teaches immune cells to target the virus more effectively from the start. The finding offers a hopeful new path for an elusive HIV vaccine.